FDA Approvals

Date Posted
Article Title
11/24/2010
Axiron Approved as First Underarm Testosterone Drug

For men with symptoms of hormone deficiency

11/19/2010
Xgeva Approved to Prevent Fractures in Bone Cancer Patients

Blocks protein that destroys bone cells

11/15/2010
Halaven Approved for Late-Stage Breast Cancer

Injected therapy believed to stifle cancer cell growth

11/15/2010
Vyvanse Approved for Adolescent ADHD

Previously sanctioned for ADHD in adults and children

11/11/2010
Egrifta Approved for HIV-Related Fat Deposits

Lipodystrophy can lead to excess fat near internal organs

11/5/2010
Kombiglyze XR Approved for Adult Type 2 Diabetes

For once-daily blood sugar control

11/5/2010
Cymbalta Approved for Chronic Joint and Muscle Pain

First approved as anti-depressant in 2004

11/4/2010
Ofirmev Sanctioned for Pain and Fever

First U.S.-approved injected form of acetaminophen

11/1/2010
Teflaro Sanctioned for Bacterial Infections

Including pneumonia and methicillin-resistant staph

11/1/2010
Afinitor Approved for Rare Genetic Disorder

Disorder causes non-cancerous brain tumors

10/28/2010
Latuda Approved for Adult Schizophrenia

Symptoms include hallucinations and delusions

10/28/2010
Sprycel Approval Expanded to Include Rare Leukemia

Drug believed to hinder proteins that encourage cancer growth

10/20/2010
Pradaxa Approved for Atrial Fibrillation

To prevent stroke in people with abnormal heart rhythm

10/18/2010
Baraclude Sanctioned for Severe Liver Disease

Among people with chronic hepatitis B

10/18/2010
Botox Approved for Chronic Migraines

For people who get migraines more than 14 days per month

10/13/2010
Vivitrol Approved to Prevent Opioid Relapse

Injected drug blocks brain's opioid receptors

9/27/2010
Contraceptive Containing a Folate Approved

Designed to help prevent certain birth defects

9/22/2010
Gilenya Approved for Relapsing MS

Oral drug designed to slow progressive disability

9/17/2010
Three Cardiac Resynchronization Defibrillators Approved for New Use

Only for certain heart failure patients, agency notes

9/15/2010
Krystexxa Approved for Gout

For adults who can't use other therapies